Cargando…
The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases
Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allerg...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768320/ https://www.ncbi.nlm.nih.gov/pubmed/36568669 http://dx.doi.org/10.1016/j.heliyon.2022.e12130 |
_version_ | 1784854139063238656 |
---|---|
author | Zhao, Yaping Liu, Rongrong Li, Miaomiao Liu, Pengfei |
author_facet | Zhao, Yaping Liu, Rongrong Li, Miaomiao Liu, Pengfei |
author_sort | Zhao, Yaping |
collection | PubMed |
description | Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allergic disorders. In recent years, more and more evidences indicate that SYK is expressed in non-hematopoietic cells and effectively regulates various non-immune biological responses as well. In this review, we mainly summary the role of SYK in different liver diseases. Robust SYK expression has been discovered in hepatocytes, hepatic stellate cells, as well as Kupffer cells, which participates in the regulation of numerous signal transduction in various liver diseases (e.g. hepatitis, liver fibrosis and hepatocellular carcinoma). In addition, the blockage of SYK activity using small molecule modulators is considered as a significant therapeutic strategy against liver diseases, and both hepatic SYK and non-hepatic SYK could become highly promising therapeutic targets. Totally, even though some critical points about the significance of SYK in liver diseases treatment still need further elaboration, more reliable biotechnical or pharmacological therapy modes will be established based on the better understanding of the relationship between SYK and liver diseases. |
format | Online Article Text |
id | pubmed-9768320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97683202022-12-22 The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases Zhao, Yaping Liu, Rongrong Li, Miaomiao Liu, Pengfei Heliyon Review Article Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allergic disorders. In recent years, more and more evidences indicate that SYK is expressed in non-hematopoietic cells and effectively regulates various non-immune biological responses as well. In this review, we mainly summary the role of SYK in different liver diseases. Robust SYK expression has been discovered in hepatocytes, hepatic stellate cells, as well as Kupffer cells, which participates in the regulation of numerous signal transduction in various liver diseases (e.g. hepatitis, liver fibrosis and hepatocellular carcinoma). In addition, the blockage of SYK activity using small molecule modulators is considered as a significant therapeutic strategy against liver diseases, and both hepatic SYK and non-hepatic SYK could become highly promising therapeutic targets. Totally, even though some critical points about the significance of SYK in liver diseases treatment still need further elaboration, more reliable biotechnical or pharmacological therapy modes will be established based on the better understanding of the relationship between SYK and liver diseases. Elsevier 2022-12-07 /pmc/articles/PMC9768320/ /pubmed/36568669 http://dx.doi.org/10.1016/j.heliyon.2022.e12130 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Article Zhao, Yaping Liu, Rongrong Li, Miaomiao Liu, Pengfei The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title_full | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title_fullStr | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title_full_unstemmed | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title_short | The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases |
title_sort | spleen tyrosine kinase (syk): a crucial therapeutic target for diverse liver diseases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768320/ https://www.ncbi.nlm.nih.gov/pubmed/36568669 http://dx.doi.org/10.1016/j.heliyon.2022.e12130 |
work_keys_str_mv | AT zhaoyaping thespleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT liurongrong thespleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT limiaomiao thespleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT liupengfei thespleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT zhaoyaping spleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT liurongrong spleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT limiaomiao spleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases AT liupengfei spleentyrosinekinasesykacrucialtherapeutictargetfordiverseliverdiseases |